A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.

• Status: Completed
• Trial end date: 2007-05-16
• Target enrollment: 0
• Participant gender: Male

Summary

This study will investigate the safety and tolerability of inhaled doses of GSK233705 with a new formulation.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion Criteria:

• Healthy male subjects 18-55 years old

• Non-Smokers

Exclusion Criteria:

• Any subject with breathing problems.

• High blood pressure and heart abnormalities.

• Any subjects currently taking prescription and non-prescription medications.